|
1
|
van Meerbeeck JP, Fennell DA and De
Ruysscher DK: Small-cell lung cancer. Lancet. 378:1741–1755. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Heist RS and Engelman JA: SnapShot:
Non-small cell lung cancer. Cancer Cell. 21:448e442. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Noda K, Nishiwaki Y, Kawahara M, Negoro S,
Sugiura T, Yokoyama A, Fukuoka M, Mori K, Watanabe K, Tamura T, et
al: Irinotecan plus cisplatin compared with etoposide plus
cisplatin for extensive small-cell lung cancer. N Engl J Med.
346:85–91. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lara PN Jr, Natale R, Crowley J, Lenz HJ,
Redman MW, Carleton JE, Jett J, Langer CJ, Kuebler JP, Dakhil SR,
et al: Phase III trial of irinotecan/cisplatin compared with
etoposide/cisplatin in extensive-stage small-cell lung cancer:
Clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol.
27:2530–2535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Network NCC: NCCN Clinical Practice
Guidelines in Oncology (NCCN Guidelines®). 2018.
|
|
6
|
Asano J, Chiba K, Tada M and Yoshii T:
Cytotoxic xanthones from Garcinia hanburyi. Phytochemistry.
41:815–820. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song JZ, Yip YK, Han QB, Qiao CF and Xu
HX: Rapid determination of polyprenylated xanthones in gamboge
resin of Garcinia hanburyi by HPLC. J Sep Sci. 30:304–309.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin T, Fang Q, Peng D, Huang X, Zhu T, Luo
Q, Zhou K and Chen W: PEGylated non-ionic surfactant vesicles as
drug delivery systems for gambogenic acid. Drug Deliv. 20:277–284.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen HB, Zhou LZ, Mei L, Shi XJ, Wang XS,
Li QL and Huang L: Gambogenic acid-induced time- and dose-dependent
growth inhibition and apoptosis involving Akt pathway inactivation
in U251 glioblastoma cells. J Nat Med. 66:62–69. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen F, Zhang XH, Hu XD, Zhang W, Lou ZC,
Xie LH, Liu PD and Zhang HQ: Enhancement of radiotherapy by ceria
nanoparticles modified with neogambogic acid in breast cancer
cells. Int J Nanomedicine. 10:4957–4969. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang L, Wang M, Cheng H and Li Q:
Gambogenic acid inhibits proliferation of A549 cells through
apoptosis-inducing. Zhongguo Zhong Yao Za Zhi. 36:1217–1221.
2011.(In Chinese). PubMed/NCBI
|
|
12
|
Cheng H, Su JJ, Peng JY, Wang M, Wang XC,
Yan FG, Wang XS and Li QL: Gambogenic acid inhibits proliferation
of A549 cells through apoptosis inducing through up-regulation of
the p38 MAPK cascade. J Asian Nat Prod Res. 13:993–1002. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Q, Cheng H, Zhu G, Yang L, Zhou A, Wang
X, Fang N, Xia L, Su J, Wang M, et al: Gambogenic acid inhibits
proliferation of A549 cells through apoptosis-inducing and cell
cycle arresting. Biol Pharm Bull. 33:415–420. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan F, Wang M, Li J, Cheng H, Su J, Wang
X, Wu H, Xia L, Li X, Chang HC, et al: Gambogenic acid induced
mitochondrial-dependent apoptosis and referred to phospho-Erk1/2
and phospho-p38 MAPK in human hepatoma HepG2 cells. Environ Toxicol
Pharmacol. 33:181–190. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan F, Wang M, Chen H, Su J, Wang X, Wang
F, Xia L and Li Q: Gambogenic acid mediated apoptosis through the
mitochondrial oxidative stress and inactivation of Akt signaling
pathway in human nasopharyngeal carcinoma CNE-1 cells. Eur J
Pharmacol. 652:23–32. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu XJ, Han QB, Wen ZS, Ma L, Gao J and
Zhou GB: Gambogenic acid induces G1 arrest via GSK3β-dependent
cyclin D1 degradation and triggers autophagy in lung cancer cells.
Cancer Lett. 322:185–194. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peng C, Sun M, Su J and Li Q: Effect of
gambogenic acid on inducing A549 cell apoptosis through regulating
Ras/Raf/Erk signaling pathway. Traditional Chin Drug Res Clin
Plarmacol. 27:189–193. 2016.
|
|
18
|
Su J, Cheng H, Zhang D, Wang M, Xie C, Hu
Y, Chang HC and Li Q: Synergistic effects of 5-fluorouracil and
gambogenic acid on A549 cells: Activation of cell death caused by
apoptotic and necroptotic mechanisms via the ROS-mitochondria
pathway. Biol Pharm Bull. 37:1259–1268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu W, Guo QL, You QD, Zhao L, Gu HY and
Yuan ST: Anticancer effect and apoptosis induction of gambogic acid
in human gastric cancer line BGC-823. World J Gastroenterol.
11:3655–3659. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yi T, Yi Z, Cho SG, Luo J, Pandey MK,
Aggarwal BB and Liu M: Gambogic acid inhibits angiogenesis and
prostate tumor growth by suppressing vascular endothelial growth
factor receptor 2 signaling. Cancer Res. 68:1843–1850. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang T, Wei J, Qian X, Ding Y, Yu L and
Liu B: Gambogic acid, a potent inhibitor of survivin, reverses
docetaxel resistance in gastric cancer cells. Cancer Lett.
262:214–222. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang K, Tang Y, Sun M, Lu B, Zhu H, Ji O
and Shen Q: The mechanism of neogambogic acid-induced apoptosis in
human MCF-7 cells. Acta Biochim Biophys Sin. 43:698–702. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen R, Zhang H, Liu P, Wu X and Chen B:
Gambogenic acid synergistically potentiates bortezomib-induced
apoptosis in multiple myeloma. J Cancer. 8:839–851. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jing G, Wang JJ and Zhang SX: ER stress
and apoptosis: A new mechanism for retinal cell death. Exp Diabetes
Res 2012. 5895892012.
|
|
26
|
Liu N, Huang H, Liu S, Li X, Yang C, Dou
QP and Liu J: Calcium channel blocker verapamil accelerates
gambogic acid-induced cytotoxicity via enhancing proteasome
inhibition and ROS generation. Toxicol In Vitro. 28:419–425. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li F, Wang Y and Yan Y: Gambogenic acid
induces cell growth inhibition, cell cycle arrest and metastasis
inhibition in choroidal melanoma in a dose-dependent manner. Exp
Ther Med. 13:2456–2462. 2017. View Article : Google Scholar : PubMed/NCBI
|
